Latest PTC Therapeutics Stories

2014-02-27 20:22:58

SOUTH PLAINFIELD, N.J., Feb. 27, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that will host a webcast conference call to discuss financial results for the fourth quarter and year end 2013 on Thursday, March 6, 2014 at 4:30 p.m. (ET) after the closing of the market. http://photos.prnewswire.com/prnvar/20010919/PTCLOGO The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the...

2014-02-25 08:32:07

SOUTH PLAINFIELD, N.J., Feb. 25, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointment of Guido Schopen, M.D. to General Manager and Head of Medical Affairs for Europe. Dr. Schopen will be responsible for European commercial operations, reporting to Mark Rothera, Chief Commercial Officer of PTC. (Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) "We are delighted to welcome Dr. Schopen to our team where he will play a key leadership role...

2014-02-20 08:31:58

SOUTH PLAINFIELD, N.J., Feb. 20, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that they will participate in two upcoming investor conferences: (Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO) - Management will participate in a panel entitled "DMD Back in the Spotlight, What's New and What's Different" which will be held from 9:40-10:25am ET on Tuesday, February 25(th) at the 2014 Citi Global Healthcare Conference in New York City. - The...

2014-01-24 08:23:41

SOUTH PLAINFIELD, N.J., Jan. 24, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced an expansion of its senior management team with the appointment of Robert J. Spiegel M.D., FACP to Chief Medical Officer and Murad Husain to Vice President, Global Regulatory Affairs. PTC also announced the promotions of Joseph Colacino, Ph.D. to Senior Vice President, Drug Discovery and Ernest R. Dietel to Senior Vice President, Quality. In addition, Jay Barth, M.D., Senior...

2014-01-22 00:21:53

SOUTH PLAINFIELD, N.J., Jan. 22, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT), the SMA Foundation, and Roche (SIX: RO, ROG; OTCQX: RHHBY), announced today that their joint research program in Spinal Muscular Atrophy (SMA) has entered the first stage of clinical development aiming to assess safety and tolerability of an oral compound in healthy volunteers. SMA is a genetic neuromuscular disorder that leads to muscle weakness and mobility impairment and is considered the...

2014-01-06 12:28:58

SOUTH PLAINFIELD, N.J., Jan. 6, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the 2014 J.P. Morgan Healthcare Conference on Monday, January 13 at 3:00 pm PT. (Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO) The presentation will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com. The presentation will be...

Word of the Day
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'